1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for
Study
1.2.3. Key Market
Segmentations
2. Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3. Executive Summary
3.1. Overview of the
Market
3.2. Overview of Key
Market Segmentations
3.3. Overview of Key
Market Players
3.4. Overview of Key
Regions/Countries
3.5. Overview of Market
Drivers, Challenges, Trends
4. Voice of Customers
5. Global Cell and Gene
Supply Chain Services Market Outlook
5.1.
Market Size & Forecast
5.1.1. By Value
5.2.
Market Share & Forecast
5.2.1. By Technology (Presence on cloud, Presence on-premises)
5.2.2. By Applications (Ordering and scheduling, Sample
collection, Logistics, Post treatment follow-up)
5.2.3. By End User (Biobank/ cell-bank, Hospitals, Research
institutes, Cell therapy labs, Others)
5.2.4. By Region
5.2.5. By Company (2023)
5.3.
Market Map
5.3.1. By Technology
5.3.2. By Applications
5.3.3. By End User
5.3.4. By Region
6. Asia Pacific Cell
and Gene Supply Chain Services Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Technology
6.2.2. By Applications
6.2.3. By End User
6.2.4. By Country
6.3.
Asia Pacific: Country Analysis
6.3.1. China Cell and Gene
Supply Chain Services Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Technology
6.3.1.2.2.
By Applications
6.3.1.2.3.
By End
User
6.3.2. India Cell and Gene
Supply Chain Services Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Technology
6.3.2.2.2.
By Applications
6.3.2.2.3.
By End
User
6.3.3. Australia Cell and
Gene Supply Chain Services Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Technology
6.3.3.2.2.
By Applications
6.3.3.2.3.
By End
User
6.3.4. Japan Cell and Gene
Supply Chain Services Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Technology
6.3.4.2.2.
By Applications
6.3.4.2.3.
By End
User
6.3.5. South Korea Cell and
Gene Supply Chain Services Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Technology
6.3.5.2.2.
By Applications
6.3.5.2.3.
By End
User
7. Europe Cell and Gene
Supply Chain Services Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Technology
7.2.2. By Applications
7.2.3. By End User
7.2.4.
By
Country
7.3.
Europe: Country Analysis
7.3.1. France Cell and Gene
Supply Chain Services Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Technology
7.3.1.2.2.
By Applications
7.3.1.2.3.
By End
User
7.3.2. Germany Cell and
Gene Supply Chain Services Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Technology
7.3.2.2.2.
By Applications
7.3.2.2.3.
By End
User
7.3.3. Spain Cell and Gene
Supply Chain Services Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Technology
7.3.3.2.2.
By Applications
7.3.3.2.3.
By End
User
7.3.4. Italy Cell and Gene
Supply Chain Services Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Technology
7.3.4.2.2.
By Applications
7.3.4.2.3.
By End
User
7.3.5. United Kingdom Cell
and Gene Supply Chain Services Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Technology
7.3.5.2.2.
By Applications
7.3.5.2.3.
By End
User
8. North America Cell
and Gene Supply Chain Services Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Technology
8.2.2. By Applications
8.2.3. By End User
8.2.4. By Country
8.3.
North America: Country Analysis
8.3.1. United States Cell
and Gene Supply Chain Services Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Technology
8.3.1.2.2.
By Applications
8.3.1.2.3.
By End
User
8.3.2. Mexico Cell and Gene
Supply Chain Services Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Technology
8.3.2.2.2.
By Applications
8.3.2.2.3.
By End
User
8.3.3. Canada Cell and Gene
Supply Chain Services Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Technology
8.3.3.2.2.
By Applications
8.3.3.2.3.
By End
User
9. South America Cell
and Gene Supply Chain Services Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Technology
9.2.2. By Applications
9.2.3. By End User
9.2.4. By Country
9.3.
South America: Country Analysis
9.3.1. Brazil Cell and Gene
Supply Chain Services Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Technology
9.3.1.2.2.
By Applications
9.3.1.2.3.
By End
User
9.3.2. Argentina Cell and
Gene Supply Chain Services Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Technology
9.3.2.2.2.
By Applications
9.3.2.2.3.
By End
User
9.3.3. Colombia Cell and
Gene Supply Chain Services Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Technology
9.3.3.2.2.
By Applications
9.3.3.2.3.
By End
User
10. Middle East and
Africa Cell and Gene Supply Chain Services Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Technology
10.2.2. By Applications
10.2.3. By End User
10.2.4. By Country
10.3.
MEA: Country Analysis
10.3.1. South Africa Cell
and Gene Supply Chain Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Technology
10.3.1.2.2.
By Applications
10.3.1.2.3.
By End
User
10.3.2. Saudi Arabia Cell
and Gene Supply Chain Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Technology
10.3.2.2.2.
By Applications
10.3.2.2.3.
By End
User
10.3.3. UAE Cell and Gene
Supply Chain Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Technology
10.3.3.2.2.
By Applications
10.3.3.2.3.
By End
User
10.3.4. Egypt Cell and Gene
Supply Chain Services Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1.
By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1.
By Technology
10.3.4.2.2.
By Applications
10.3.4.2.3.
By End
User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends &
Developments
12.1.
Recent Developments
12.2.
Product Launches ( If Any)
12.3.
Mergers & Acquisitions ( If Any)
13. Global Cell and Gene
Supply Chain Services Market: SWOT Analysis
14. Porter’s Five Forces
Analysis
14.1.
Competition in the Industry
14.2.
Potential of New Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute Product
15. Competitive
Landscape
15.1. Biocair International Limited
15.1.1.
Business Overview
15.1.2.
Company Snapshot
15.1.3.
Products & Services
15.1.4.
Financials (As Reported)
15.1.5.
Recent Developments
15.1.6.
Key Personnel Details
15.1.7.
SWOT Analysis
15.2. Arvato SE
15.3. Associated Couriers,
LLC.
15.4. TrakCel Limited
15.5. Parkoursc Inc.
15.6. DHL
15.7. McKesson Corporation
15.8. Almac Group Limited
15.9. Catalent Inc.
15.10. Biostor Ltd.
16. Strategic
Recommendations
17. About Us & Disclaimer